Adjuvant chemotherapy is an approach to fighting cancer that combines different forms of healing. Chemotherapy and radiation, or chemotherapy and surgery are used together. Usually the chemotherapy will be used after all of the known and visible cancer has been removed surgically or with radiation. Adjuvant chemotherapy aims to destroy hidden cancer cells that remain but are undetectable.
Adjuvant means additional. Adjuvant chemotherapy is given to patients after primary treatment, when the doctor thinks there is a high risk the cancer will return. After a primary treatment of surgery or radiation, adjuvant chemotherapy reduces the risk of recurrence. The elimination of undetectable microscopic cancer cells that may have traveled to other parts of the body is the goal of adjuvant chemotherapy.
When adjuvant chemotherapy doesn’t result in a full cure, it does make the intervals between a cancer relapse longer. Adjuvant chemotherapy typically begins within three to five weeks of the surgical removal of the cancer and has different treatment lengths depending on the cancer. For breast cancer the adjuvant chemotherapy is administered for three to nine months. In the case of colon cancer treatment rarely last more than six months.
Neoadjuvant chemotherapy is the administration of drugs before surgery or radiation therapy. The reduction in size of larger tumors, or to prevent metastatic cancer from spreading, is the goal of neoadjuvant chemotherapy. Breast, head, and neck tumors can be more successfully removed after they were shrunk by neoadjuvant chemotherapy.
Adjuvant chemotherapy is used for:
- Breast cancer
- Colon cancer
- Testicular cancer
- Ovarian cancer
- Lung cancer
- Pancreatic cancer
It is commonly used for breast cancer, especially under the following conditions: when cancer cells have been found in the lymph nodes during breast tumor removal surgery, when there was a large tumor that indicated a high possibility of metastasis, in the presence of an aggressive and high-grade pathology, or if a tumor has negative hormone receptors. Women under 50 reduced their risk of a recurrence by 35%, and women over 50 reduced their risk by 20 percent.
It is difficult to measure the success of adjuvant chemotherapy in absolutes, because the treatment is administered in the absence of detectable amounts of cancerous cells.
Patients who went through surgery or radiotherapy to rid their body of cancer are often confused when they are counseled to go through adjuvant chemotherapy. Instead of attacking cancer that is visible in x-rays, CAT scans, or lab results, the adjuvant chemotherapy is designed as a sort of insurance against the threat of possible cancer cells causing new damage in other areas of the body. Fear of chemotherapy side effects such as hair loss, nausea, or vomiting need to be heard and addressed.
The percentages of patients receiving adjuvant chemotherapy are dependent on their type of cancer. In deciding if a patient should receive the therapy the possible benefit is weighed against the survival rate without adjuvant chemotherapy. A careful evaluation of every patient’s personal situation in collaboration with the oncologist is needed to figure out the best follow up after cancer. Here are some questions you may wish to ask your doctor.
Everyone’s Guide to Cancer Supportive Care by Ernest H. Rosenbaum, M.D, and Isadora Rosenbaum M.A. 2005, pages 41, 544.
Dr. Susan Love’s Breast Book. Susan M. Love, M.D. 2000, page 381.
Des Guetz G, Uzzan B, Morere J-F, Perret G, Nicolas P. Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007046. DOI: 10.1002/14651858.CD007046.pub2